| Symbol | CBIO |
|---|---|
| Name | CRESCENT BIOPHARMA, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 9708 MEDICAL CENTER DRIVE, ROCKVILLE, Maryland, 20850, United States |
| Telephone | +1 240 243-1201 |
| Fax | — |
| — | |
| Website | https://www.glycomimetics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001253689 |
| Description | GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Additional info from NASDAQ: |
(75% Positive) CRESCENT BIOPHARMA, INC. (CBIO) Announces Enrollment Update for beginning Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment
Read moreCrescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Read moreNew Form POS AM - CRESCENT BIOPHARMA, INC. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001628280-26-050885 <b>Size:</b> 386 KB
Read moreNew Form 424B3 - CRESCENT BIOPHARMA, INC. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001628280-26-050881 <b>Size:</b> 1 MB
Read moreDirector Fairmount Funds Management LLC 🟢 acquired 1.4M shares (1 derivative) of CRESCENT BIOPHARMA, INC. (CBIO) at $14.50 ($12.4M) Transaction Date: Jul 16, 2026 | Filing ID: 085113
Read moreNew Form SCHEDULE 13D/A - CRESCENT BIOPHARMA, INC. <b>Filed:</b> 2026-07-20 <b>AccNo:</b> 0001104659-26-085114 <b>Size:</b> 22 KB
Read moreCrescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read more(99% Neutral) CRESCENT BIOPHARMA, INC. (CBIO) Announces Clinical Development Update
Read moreNew Form 424B5 - CRESCENT BIOPHARMA, INC. <b>Filed:</b> 2026-07-15 <b>AccNo:</b> 0001628280-26-048344 <b>Size:</b> 594 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07335497 | CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | Phase1 | Locally Advanced / Metastatic Solid Tumors | Recruiting | 2026-02-17 | 2029-02-01 | ClinicalTrials.gov |
| NCT07293572 | Disaster Medicine Training for Pre-Clinical Medical Students at the University … | Na | Disaster Medicine Education and Preparedness Among Medical Students | Completed | 2025-07-22 | 2025-10-14 | ClinicalTrials.gov |
| NCT01787656 | A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Muc… | — | Ovarian Cancer | Completed | 2013-01-01 | 2018-08-01 | ClinicalTrials.gov |
| NCT02797353 | Strengthening Maternal Neonatal and Child Health Services in a Rural District o… | Na | Antepartum Hemorrhage | Completed | 2013-01-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT03463720 | Outcome for Patients With War-Associated Extremity Wound Infection | — | Wounds and Injuries | Completed | 2010-09-27 | 2012-05-09 | ClinicalTrials.gov |
| NCT00266487 | The Norwegian Vitamin Trial (NORVIT) | Na | Acute Myocardial Infarction | Completed | 1998-12-01 | 2004-03-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| Structured Disaster Medicine Training Program | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | COMPLETED | NCT07293572 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| Vitamin B6 | Other | Approved | Acute Myocardial Infarction | COMPLETED | NCT00266487 |
| Vitamin B12 | Other | Approved | Acute Myocardial Infarction | COMPLETED | NCT00266487 |
| Folic acid | Other | Approved | Acute Myocardial Infarction | COMPLETED | NCT00266487 |
| Vitamin B6 | Other | Approved | Acute Myocardial Infarction | COMPLETED | NCT00266487 |
| Vitamin B12 | Other | Approved | Acute Myocardial Infarction | COMPLETED | NCT00266487 |
| Folic acid | Other | Approved | Acute Myocardial Infarction | COMPLETED | NCT00266487 |
| Not infected | Other | Preclinical | Wounds and Injuries | COMPLETED | NCT03463720 |
| Infected | Other | Preclinical | Wounds and Injuries | COMPLETED | NCT03463720 |
| Not infected | Other | Preclinical | Wounds and Injuries | COMPLETED | NCT03463720 |
| Infected | Other | Preclinical | Wounds and Injuries | COMPLETED | NCT03463720 |
| Maternal Neonatal and Child Health Interventions | Other | Approved | Antepartum Hemorrhage | COMPLETED | NCT02797353 |
| Maternal Neonatal and Child Health Interventions | Other | Approved | Antepartum Hemorrhage | COMPLETED | NCT02797353 |
| Specialized Training Course in Disaster and Emergency Medicine | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | ACTIVE_NOT_RECRUITING | NCT07293572 |
| Specialized Training Course in Disaster and Emergency Medicine | Other | Approved | Disaster Medicine Education and Preparedness Among Medical Students | ACTIVE_NOT_RECRUITING | NCT07293572 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | Other | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |
| CR-001 | DRUG | Phase PHASE1 | Locally Advanced / Metastatic Solid Tumors | RECRUITING | NCT07335497 |